# A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

> **NCT03809000** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **RTOG Foundation, Inc.** · enrollment: 188 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiation Therapy
- **DRUG:** Enzalutamide
- **DRUG:** Bicalutamide
- **DRUG:** GnRH analog

## Key facts

- **NCT ID:** NCT03809000
- **Lead sponsor:** RTOG Foundation, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-04-15
- **Primary completion:** 2023-04-07
- **Final completion:** 2029-09-15
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809000, "A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03809000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*